Felix J.F

Sep 16, 2024 | karger.com | van Dijk |T. E. David |Felix J.F |A. Susanne

This content is only available via PDF. This work is licensed under a Creative Commons Attribution 4.0 International License .

Aug 13, 2024 | karger.com | Felix J.F

Introduction Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) can be limited by the inadequacy of intact tissues, especially in patients with lymphoma, sarcoidosis, and lymph node tuberculosis. A novel technique called transbronchial node biopsy (TBNB) by forceps or cryoprobe has been proposed and studied to improve specimen quality and diagnostic yield.

Jul 22, 2024 | karger.com | Felix J.F

Introduction: To establish an ultrasonographic radiomics machine learning model based on endobronchial ultrasound (EBUS) to assist in diagnosing benign and malignant mediastinal and hilar lymph nodes (LNs). Methods: The clinical and ultrasonographic image data of 197 patients were retrospectively analyzed. The radiomics features extracted by EBUS-based radiomics were analyzed by the least absolute shrinkage and selection operator (LASSO).

Mar 18, 2024 | karger.com | Felix J.F

Keywords: Lung tumors, Thermal ablation, Immunotherapy, Combined therapy Lung cancer is a highly invasive and common disease that has become a worldwide public health challenge [1, 2]. Among lung cancer cases, non-small cell lung cancer (NSCLC) accounts for approximately 87% of diagnoses. Nowadays, surgical intervention stands as the gold standard treatment strategy for patients suffering from early-stage NSCLC, with a 5-year overall survival (OS) of 78.9–82% [3, 4].

Feb 21, 2024 | karger.com | Felix J.F

Background: Early detection and accurate diagnosis of pulmonary nodules are crucial for improving patient outcomes. While surgical resection of malignant nodules is still the preferred treatment option, it may not be feasible for all patients. We aimed to discuss the advances in the treatment of pulmonary nodules, especially stereotactic body radiotherapy (SBRT) and interventional pulmonology technologies, and provide a range of recommendations based on our expertise and experience.